Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer

The aim of this study was to retrospectively compare the efficacy and toxicity of the oxaliplatin + 5-fluorouracil (5-FU) + leucovorin (LV) regimen [modified (m)FOLFOX-6] with that of the docetaxel + cisplatin + 5-FU regimen (DCF) in patients with advanced gastric cancer (AGC). A total of 72 patient...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Clin Oncol
Egile Nagusiak: HACIBEKIROGLU, ILHAN, KODAZ, HILMI, ERDOGAN, BULENT, TURKMEN, ESMA, ESENKAYA, ASIM, ONAL, YILMAZ, UZUNOGLU, SERNAZ, CICIN, IRFAN
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2015
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534881/
https://ncbi.nlm.nih.gov/pubmed/26623070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.592
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak